These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 23042505)
1. Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: validation of molecular markers and technology innovation. Papale F; Cafiero G; Grimaldi A; Marino G; Rosso F; Mian C; Barollo S; Pennelli G; Sorrenti S; De Antoni E; Barbarisi A J Cell Physiol; 2013 May; 228(5):968-74. PubMed ID: 23042505 [TBL] [Abstract][Full Text] [Related]
2. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms. Aron M; Kapila K; Verma K Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889 [TBL] [Abstract][Full Text] [Related]
3. Fine needle aspiration cytology in diagnosis and management of thyroid disease. Bajaj Y; De M; Thompson A J Laryngol Otol; 2006 Jun; 120(6):467-9. PubMed ID: 16526971 [TBL] [Abstract][Full Text] [Related]
4. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma. Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177 [TBL] [Abstract][Full Text] [Related]
5. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations]. Hayashi N; Kitaoka M Nihon Rinsho; 2007 Nov; 65(11):2003-7. PubMed ID: 18018562 [TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma]. Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965 [TBL] [Abstract][Full Text] [Related]
7. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105 [TBL] [Abstract][Full Text] [Related]
8. Immunogold labelling in environmental scanning electron microscopy: applicative features for complementary cytological interpretation. Cafiero G; Papale F; Grimaldi A; Rosso F; Barbarisi M; Tortora C; Marino G; Barbarisi A J Microsc; 2011 Jan; 241(1):83-93. PubMed ID: 21118204 [TBL] [Abstract][Full Text] [Related]
9. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653 [TBL] [Abstract][Full Text] [Related]
10. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators. Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527 [TBL] [Abstract][Full Text] [Related]
11. An updated audit of fine needle aspiration cytology procedure of solitary thyroid nodule. Bukhari MH; Niazi S; Hanif G; Qureshi SS; Munir M; Hasan M; Naeem S Diagn Cytopathol; 2008 Feb; 36(2):104-12. PubMed ID: 18181183 [TBL] [Abstract][Full Text] [Related]
12. [A comparative study of cytological and histological studies of the thyroid gland]. Emmrich P; Gauer G; Gauer J; Mättig H; Rosenkranz M Zentralbl Chir; 2001 Apr; 126(4):267-72. PubMed ID: 11370387 [TBL] [Abstract][Full Text] [Related]
13. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634 [TBL] [Abstract][Full Text] [Related]
14. Divide and rule: cytodiagnosis of thyroid lesions using pattern analysis: a study of 233 cases. MuddeGowda PH; Lingegowda J; Natesan R; Kurpad R Diagn Cytopathol; 2011 Dec; 39(12):888-95. PubMed ID: 22081525 [TBL] [Abstract][Full Text] [Related]
15. Role of pro-angiogenic marker galectin-3 in follicular neoplasms of thyroid. Manivannan P; Siddaraju N; Jatiya L; Verma SK Indian J Biochem Biophys; 2012 Oct; 49(5):392-4. PubMed ID: 23259327 [TBL] [Abstract][Full Text] [Related]
16. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Sapio MR; Guerra A; Posca D; Limone PP; Deandrea M; Motta M; Troncone G; Caleo A; Vallefuoco P; Rossi G; Fenzi G; Vitale M Endocr Relat Cancer; 2007 Dec; 14(4):1089-97. PubMed ID: 18045960 [TBL] [Abstract][Full Text] [Related]
17. [Galectin-3 in differential diagnosis and prognosis of follicular tumors of the thyroid gland]. Iushkov PV; Antonova SS; Bartolazzi A Arkh Patol; 2004; 66(6):39-42. PubMed ID: 15648166 [TBL] [Abstract][Full Text] [Related]
18. Use and accuracy of fine-needle aspiration cytology in histologically proven thyroid carcinoma: an audit using a national nathology database. Giard RW; Hermans J Cancer; 2000 Dec; 90(6):330-4. PubMed ID: 11156515 [TBL] [Abstract][Full Text] [Related]
19. Galectin-1 is a diagnostic marker involved in thyroid cancer progression. Arcolia V; Journe F; Wattier A; Leteurtre E; Renaud F; Gabius HJ; Remmelink M; Decaestecker C; Rodriguez A; Boutry S; Laurent S; Saussez S Int J Oncol; 2017 Sep; 51(3):760-770. PubMed ID: 28677745 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic pitfalls in the evaluation of fine needle aspiration cytology of the thyroid: correlation with histopathology in 260 cases. Haberal AN; Toru S; Ozen O; Arat Z; Bilezikçi B Cytopathology; 2009 Apr; 20(2):103-8. PubMed ID: 18713250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]